Mural Oncology plc

MURA

$2.04

Name : Mural Oncology plc

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $35,382,752.00

EPSttm : -6.93

Mural Oncology plc

$2.04

0.00%

$2.04

Float Short %

2.72

Margin Of Safety %

Put/Call OI Ratio

0.26

EPS Next Q Diff

EPS Last/This Y

1.92

EPS This/Next Y

5.27

Price

2.04

Target Price

Analyst Recom

Performance Q

-1.45

Relative Volume

Beta

2.93

Ticker: MURA

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-11-11	MURA	2.09	0.25	0.00	24841
2025-11-12	MURA	2.09	0.25	0.00	24841
2025-11-13	MURA	2.09	0.25	0.00	24841
2025-11-14	MURA	2.09	0.25	0.00	24841
2025-11-17	MURA	2.09	0.25	0.00	24842
2025-11-18	MURA	2.08	0.25	10.00	24893
2025-11-19	MURA	2.08	0.25	10.00	24893
2025-11-20	MURA	2.1	0.25	10.00	24893
2025-11-21	MURA	2.1	0.25	10.00	24893
2025-11-24	MURA	2.09	0.25	10.00	24893
2025-11-25	MURA	2.09	0.26	0.00	25113
2025-11-26	MURA	2.03	0.26	0.00	25113
2025-12-01	MURA	2.03	0.26	0.00	25114
2025-12-02	MURA	2.03	0.26	999.99	25115
2025-12-03	MURA	2.035	0.26	999.99	25115
2025-12-04	MURA	2.04	0.26	999.99	25116
2025-12-05	MURA	2.04	0.26	999.99	25116
2025-12-08	MURA	2.04	0.26	999.99	25116
2025-12-09	MURA	2.04	0.26	999.99	25116
2025-12-10	MURA	2.04	0.26	999.99	25116
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-11-11	MURA	2.10	68.5	-	-5.66
2025-11-12	MURA	2.08	68.5	-	-5.66
2025-11-13	MURA	2.09	68.5	-	-5.66
2025-11-14	MURA	2.09	81.6	-	-5.66
2025-11-17	MURA	2.09	81.6	-	-5.66
2025-11-18	MURA	2.09	81.6	-	-5.66
2025-11-19	MURA	2.08	81.6	-	-5.66
2025-11-20	MURA	2.09	81.6	-	-5.66
2025-11-21	MURA	2.10	81.6	-	-5.66
2025-11-24	MURA	2.09	81.6	-	-5.66
2025-11-25	MURA	2.10	81.6	-	-5.66
2025-11-26	MURA	2.03	81.6	-	-5.66
2025-12-01	MURA	2.03	81.6	-	-5.66
2025-12-02	MURA	2.03	81.6	-	-5.66
2025-12-03	MURA	2.04	81.6	-	-5.66
2025-12-04	MURA	2.03	81.6	-	-5.66
2025-12-05	MURA	0.00	81.6	-	-5.66
2025-12-08	MURA	0.00	81.6	-	-5.66
2025-12-09	MURA	0.00	81.6	-	-5.66
2025-12-10	MURA	2.04	81.6	-	-5.66
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-11-11	MURA	-0.99	-9.69	2.96
2025-11-12	MURA	-0.99	-9.69	2.84
2025-11-13	MURA	-0.99	-9.69	2.84
2025-11-14	MURA	-0.99	-9.69	2.86
2025-11-17	MURA	-0.96	-2.15	2.68
2025-11-18	MURA	-1.40	-2.15	2.68
2025-11-19	MURA	-1.40	-2.15	2.68
2025-11-20	MURA	-1.40	-2.15	2.68
2025-11-21	MURA	-1.40	-2.15	2.68
2025-11-24	MURA	-1.40	-16.97	2.57
2025-11-25	MURA	-2.03	-16.97	2.57
2025-11-26	MURA	-2.03	-16.97	2.62
2025-12-01	MURA	-2.03	-16.89	2.62
2025-12-02	MURA	-2.03	-16.89	2.62
2025-12-03	MURA	-2.03	-16.89	2.62
2025-12-04	MURA	-2.03	-16.89	2.62
2025-12-05	MURA	-2.03	-16.89	2.62
2025-12-08	MURA	-2.03	-16.45	2.62
2025-12-09	MURA	-2.03	-16.45	2.62
2025-12-10	MURA	-2.03	-16.45	2.72
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

-0.21

Avg. EPS Est. Current Quarter

-0.37

Avg. EPS Est. Next Quarter

Insider Transactions

-2.03

Institutional Transactions

-16.45

Beta

2.93

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

0.64

P/Free Cash Flow

EPS

-6.93

Average EPS Est. Cur. Y

-5.66

EPS Next Y. (Est.)

-0.39

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

-242.6

Return on Equity vs Industry %

-227.7

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Mural Oncology plc

Sector: Healthcare

Industry: Biotechnology

Employees: 116

Mural Oncology plc operates as a clinical-stage oncology company that focuses on discovering and developing immunotherapies for the treatment of patients with cancer. The company's lead product candidate includes nemvaleukin alfa for the treatment of mucosal melanoma as a monotherapy and platinum-resistant ovarian cancer in combination with pembrolizumab. It also develops nemvaleukin to treat cutaneous melanoma and advanced solid tumors. The company also develops engineered interleukin-18 and tumor-targeted interleukin-12 programs. Mural Oncology plc was incorporated in 2017 and is based in Dublin, Ireland. As of December 4, 2025, Mural Oncology plc operates as a subsidiary of XOMA Royalty Corporation.

stock quote shares MURA – Mural Oncology plc Stock Price stock today

news today MURA – Mural Oncology plc stock forecast ,stock prediction 2023 2024 2025

marketwatch MURA – Mural Oncology plc yahoo finance google finance

stock history MURA – Mural Oncology plc invest stock market

stock prices MURA premarket after hours

ticker MURA fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: MURA

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y